Skip to main content

Part of the book series: Medical Intelligence Unit ((MIUN))

Abstract

The presence of allogeneic leukocytes in blood products received little attention until the mid-1950s when these “passenger” cells were implicated in the etiology of febrile transfusion reactions, and early strategies based on centrifugation were developed to effect their removal. In recent decades and, particularly in the past five years, there has been an accumulation of literature implicating leukocytes in a wide variety of undesirable reactions to blood transfusion.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 16.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 1995 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Sweeney, J., Heaton, A. (1995). Introduction. In: Clinical Benefits of Leukodepleted Blood Products. Medical Intelligence Unit. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-26538-3_1

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-26538-3_1

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-1-57059-122-8

  • Online ISBN: 978-3-662-26538-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics